Cabaletta Bio (CABA) Revenue & Revenue Breakdown
Cabaletta Bio Revenue Highlights
00
Cabaletta Bio Revenue by Period
Cabaletta Bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Cabaletta Bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $4.01M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
Cabaletta Bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ACLX | Arcellx | $110.32M | $26.03M |
ALEC | Alector | $97.06M | $15.08M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
PLRX | Pliant Therapeutics | $1.58M | - |
FIXX | Q32 Bio | $1.16M | - |
BCEL | Atreca | $770.00K | $80.00K |
BDTX | Black Diamond Therapeutics | - | - |
CABA | Cabaletta Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
PASG | Passage Bio | - | - |
LRMR | Larimar Therapeutics | - | - |
ETNB | 89bio | - | - |